Martens Pieter
Kauffman Center for Heart Failure Treatment and Recovery, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute Cleveland Clinic, Cleveland, OH, US.
Card Fail Rev. 2022 Mar 16;8:e06. doi: 10.15420/cfr.2021.26. eCollection 2022 Jan.
Over the past decade, the detrimental impact of iron deficiency in heart failure with reduced ejection fraction has become abundantly clear, showing a negative impact on functional status, quality of life, cardiac function and structure, exercise capacity and an increased risk of hospitalisation due to heart failure. Mechanistic studies have shown the impact of iron deficiency in altering mitochondrial function and negatively affecting the already altered cardiac energetics in heart failure with reduced ejection fraction. Such failing energetics form the basis of the alterations to cellular myocyte shortening, culminating in reduced systolic function and cardiac performance. The IRON-CRT trials show that ferric carboxymaltose is capable of improving cardiac structure and cardiac performance. This article discusses the effect of iron deficiency on cardiac function and structure and how it can be alleviated.
在过去十年中,缺铁对射血分数降低的心力衰竭的有害影响已变得十分明显,显示出对功能状态、生活质量、心脏功能和结构、运动能力以及因心力衰竭住院风险增加的负面影响。机制研究表明,缺铁在射血分数降低的心力衰竭中改变线粒体功能并对已经改变的心脏能量代谢产生负面影响。这种能量代谢失败构成了心肌细胞缩短改变的基础,最终导致收缩功能和心脏性能降低。IRON-CRT试验表明,羧基麦芽糖铁能够改善心脏结构和心脏性能。本文讨论了缺铁对心脏功能和结构的影响以及如何缓解这种影响。